Toxic shock syndrome differential diagnosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 119: | Line 119: | ||
|✔ | |✔ | ||
| | | | ||
* Positive Nikolsky sign (exerting mechanical pressure on several erythematous zones resluts in peeling of skin) | * Positive Nikolsky sign (exerting mechanical pressure on several [[erythematous]] zones resluts in peeling of skin) | ||
* Skin macules which rapidly coalescence.<ref name="pmid211627213">{{cite journal |vauthors=Harr T, French LE |title=Toxic epidermal necrolysis and Stevens-Johnson syndrome |journal=Orphanet J Rare Dis |volume=5 |issue= |pages=39 |year=2010 |pmid=21162721 |pmc=3018455 |doi=10.1186/1750-1172-5-39 |url=}}</ref> | * Skin [[Macule|macules]] which rapidly [[Coalescence (chemistry)|coalescence]].<ref name="pmid211627213">{{cite journal |vauthors=Harr T, French LE |title=Toxic epidermal necrolysis and Stevens-Johnson syndrome |journal=Orphanet J Rare Dis |volume=5 |issue= |pages=39 |year=2010 |pmid=21162721 |pmc=3018455 |doi=10.1186/1750-1172-5-39 |url=}}</ref> | ||
| | | | ||
* Ocular involvement: eyelid edema, | * [[Ocular]] involvement: eyelid [[edema]], [[erythema]], crusts, and ocular [[discharge]], to [[Conjunctival|conjunctival membrane]] or pseduomembrane formation or [[Cornea|corneal]] erosion<ref name="pmid17251797">{{cite journal |vauthors=Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM |title=Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management |journal=Cornea |volume=26 |issue=2 |pages=123–9 |year=2007 |pmid=17251797 |doi=10.1097/ICO.0b013e31802eb264 |url=}}</ref> | ||
* Rash: '''Purpuric macules and targetoid lesions; full-thickness epidermal necrosis,''' '''presenting as blisters and areas of denuded skin; and mucous membrane involvement'''<ref name="pmid21162721">{{cite journal |vauthors=Harr T, French LE |title=Toxic epidermal necrolysis and Stevens-Johnson syndrome |journal=Orphanet J Rare Dis |volume=5 |issue= |pages=39 |year=2010 |pmid=21162721 |pmc=3018455 |doi=10.1186/1750-1172-5-39 |url=}}</ref> | * Rash: '''[[Purpura|Purpuric]] [[Macule|macules]] and targetoid lesions; full-thickness [[epidermal]] [[necrosis]],''' '''presenting as [[Blister|blisters]] and areas of denuded skin; and [[mucous membrane]] involvement'''<ref name="pmid21162721">{{cite journal |vauthors=Harr T, French LE |title=Toxic epidermal necrolysis and Stevens-Johnson syndrome |journal=Orphanet J Rare Dis |volume=5 |issue= |pages=39 |year=2010 |pmid=21162721 |pmc=3018455 |doi=10.1186/1750-1172-5-39 |url=}}</ref> | ||
| | | | ||
* Serum levels of the following are typically elevated in patients with Stevens-Johnson syndrome: | * Serum levels of the following are typically elevated in patients with [[Stevens-Johnson syndrome]]: | ||
** Tumor necrosis factor (TNF)-alpha | ** [[Tumor necrosis factor-alpha|Tumor necrosis factor (TNF)-alpha]] | ||
** Soluble interleukin 2-receptor | ** Soluble [[interleukin 2]]-receptor | ||
** Interleukin 6 | ** [[Interleukin 6]] | ||
** C-reactive protein | ** [[C-reactive protein]] | ||
* Histological work up of skin sections reveal wide spread necrotic epidermis involving all layers | * Histological work up of skin sections reveal wide spread [[Necrosis|necrotic]] [[Epidermis (skin)|epidermis]] involving all layers | ||
|- | |- | ||
|Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome | |Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome |
Revision as of 17:56, 31 May 2017
Toxic shock syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Toxic shock syndrome differential diagnosis On the Web |
American Roentgen Ray Society Images of Toxic shock syndrome differential diagnosis |
Risk calculators and risk factors for Toxic shock syndrome differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
Toxic shock syndrome (TSS) may have a similar presentation to some diseases which present as a rash, fever and hypotension. Some features are unique to toxic shock syndrome and can be used to differentiate it from other diseases.
Differentiating Toxic Shock Syndrome from other Diseases
Toxic shock syndrome requires all 3 manifestations of fever, hypotension and diffuse scarlatiniform rash (innumerable small red papules that are diffusely distributed plus erythema, which blanches and desquamates one or two weeks after onset of illness). It presents with various signs of infection, hemodynamic dysfunction and organ failure.
Clinical presentation of fever, hypotension and rash must be differentiated from other diseases like:
Clinical presentation of fever and rash must be differentiated from other diseases like:
- Gram-negative sepsis
- Scarlet fever
- Viral exanthem
- Rickettsial disease
- Kawasaki disease
- Staphylococcal scalded skin syndrome
- Exfoliative erythroderma syndrome
- Erythema multiforme major
- Drug eruption
Common Differential Diagnoses in Patients with Fever and Rash
Disease | Epidemiology | Predisposing factors | Clinical features[1] | Lab abnormalities | ||||
---|---|---|---|---|---|---|---|---|
SignsSigns | Symptoms | |||||||
Toxic shock syndrome | Occurs in both adults and children (9:1 female predominance) |
(C. sordellii). |
Fever | Hypotension | Diffuse Rash | Other signs | ||
✔ | ✔ | ✔ |
|
|
| |||
Meningococcemia | Occurs in young adults living in close proximity (college dorms, military recruits)[6] |
|
✔ | ✔ | ✔ |
|
| |
Steven Johnson syndrome (SJS) | Triggered by certain medications, most commonly:
|
✔ | ✔ | ✔ |
|
| ||
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome | ✔ | ✔ | ✔ |
|
| |||
Redman syndrome | ||||||||
Kawasaki | Occurs in children, usually age 1-4 years |
|
✔ | ✔ | ✔ |
|
High and persistent fever that is not very responsive to normal treatment with acetaminophen or NSAIDs, diffuse macular-papular erythematous rash | Liver function tests may show evidence of hepatic inflammation and low serum albumin levels, low hemoglobulin and age-adjusted hemoglobulin concentrations, thrombocytosis, anemia. Echocardiographic abnormalities, such as valvulitis (mitral or tricuspid regurgitation) and coronary artery lesions, are significantly more common in Kawasaki disease. [21] Pyuria of uretheral origin. |
Scarlet fever | Distributed equally among both genders. Most commonly affects children between five and fifteen years of age. | Occurs after streptococcal pharyngitis/tonsillitis | Pastia's sign (puncta and skin crease accentuation of the erythema), strawberry tongue, cervical lymphadenopathy may be present. Scarlet fever appears similar to Kawasaki's disease in some aspects, but lacks the eye signs or the swollen, red fingers and toes | Characteristic sandpaper-like rash which appears days after the illness begins (although the rash can appear before illness or up to 7 days later), rash may first appear on the neck, underarm, and groin | Leukocytosis with left shift and possibly eosinophilia a few weeks after convalescence. Anti-deoxyribonuclease B, antistreptolysin-O titers (antibodies to streptococcal extracellular products), antihyaluronidase, and antifibrinolysin may be positive. |
Less common Differential Diagnoses in Patients with Fever and Rash
Disease | Features |
---|---|
Impetigo | |
Insect bites |
|
Kawasaki disease |
|
Measles |
|
Monkeypox |
|
Rubella |
|
Atypical measles |
|
Coxsackievirus |
|
Acne |
|
Syphilis | It commonly presents with gneralized systemic symptoms such as malaise, fatigue, headache and fever. Skin eruptions may be subtle and asymptomatic It is classically described as:
|
Molluscum contagiosum |
|
Mononucleosis |
|
Toxic erythema | |
Rat-bite fever | |
Parvovirus B19 | |
Cytomegalovirus |
|
Scarlet fever |
|
Rocky Mountain spotted fever |
|
Stevens-Johnson syndrome |
|
Varicella-zoster virus | |
Chickenpox |
|
Meningococcemia |
|
Rickettsial pox | |
Meningitis |
|
References
- ↑ Todd JK (1988). "Toxic shock syndrome". Clin. Microbiol. Rev. 1 (4): 432–46. PMC 358064. PMID 3069202.
- ↑ Kang JH (2015). "Febrile Illness with Skin Rashes". Infect Chemother. 47 (3): 155–66. doi:10.3947/ic.2015.47.3.155. PMC 4607768. PMID 26483989.
- ↑ Brook MG, Bannister BA (1988). "Scarlet fever can mimic toxic shock syndrome". Postgrad Med J. 64 (758): 965–7. PMC 2429080. PMID 3256819.
- ↑ Minemura M, Tajiri K, Shimizu Y (2014). "Liver involvement in systemic infection". World J Hepatol. 6 (9): 632–42. doi:10.4254/wjh.v6.i9.632. PMC 4179142. PMID 25276279.
- ↑ Chesney RW, Chesney PJ, Davis JP, Segar WE (1981). "Renal manifestations of the staphylococcal toxic-shock syndrome". Am. J. Med. 71 (4): 583–8. PMID 7282746.
- ↑ Harrison LH (2010). "Epidemiological profile of meningococcal disease in the United States". Clin. Infect. Dis. 50 Suppl 2: S37–44. doi:10.1086/648963. PMC 2820831. PMID 20144015.
- ↑ MacLennan J, Kafatos G, Neal K, Andrews N, Cameron JC, Roberts R, Evans MR, Cann K, Baxter DN, Maiden MC, Stuart JM (2006). "Social behavior and meningococcal carriage in British teenagers". Emerging Infect. Dis. 12 (6): 950–7. PMC 3373034. PMID 16707051.
- ↑ WARTENBERG R (1950). "The signs of Brudzinski and of Kernig". J. Pediatr. 37 (4): 679–84. PMID 14779273.
- ↑ Bush LM (2014). "Case 28-2014: A man with a rash, headache, fever, nausea, and photophobia". N. Engl. J. Med. 371 (23): 2238–9. doi:10.1056/NEJMc1412237#SA2. PMID 25470712.
- ↑ 10.0 10.1 "Meningitis Symptoms - Meningitis Research Foundation".
- ↑ Techasatian L, Panombualert S, Uppala R, Jetsrisuparb C (2016). "Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children: 20 years study in a tertiary care hospital". World J Pediatr. doi:10.1007/s12519-016-0057-3. PMID 27650525.
- ↑ Harr T, French LE (2010). "Toxic epidermal necrolysis and Stevens-Johnson syndrome". Orphanet J Rare Dis. 5: 39. doi:10.1186/1750-1172-5-39. PMC 3018455. PMID 21162721.
- ↑ Chung WH, Hung SI, Hong HS, Hsih MS, Yang LC, Ho HC, Wu JY, Chen YT (2004). "Medical genetics: a marker for Stevens-Johnson syndrome". Nature. 428 (6982): 486. doi:10.1038/428486a. PMID 15057820.
- ↑ Harr T, French LE (2010). "Toxic epidermal necrolysis and Stevens-Johnson syndrome". Orphanet J Rare Dis. 5: 39. doi:10.1186/1750-1172-5-39. PMC 3018455. PMID 21162721.
- ↑ Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM (2007). "Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management". Cornea. 26 (2): 123–9. doi:10.1097/ICO.0b013e31802eb264. PMID 17251797.
- ↑ Harr T, French LE (2010). "Toxic epidermal necrolysis and Stevens-Johnson syndrome". Orphanet J Rare Dis. 5: 39. doi:10.1186/1750-1172-5-39. PMC 3018455. PMID 21162721.
- ↑ Choudhary S, McLeod M, Torchia D, Romanelli P (2013). "Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome". J Clin Aesthet Dermatol. 6 (6): 31–7. PMC 3718748. PMID 23882307.
- ↑ Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V (2009). "Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure". Arch Dermatol. 145 (1): 67–72. doi:10.1001/archderm.145.1.67. PMID 19153346.
- ↑ Peyrière H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, Hillaire-Buys D (2006). "Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?". Br. J. Dermatol. 155 (2): 422–8. doi:10.1111/j.1365-2133.2006.07284.x. PMID 16882184.
- ↑ Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, Chosidow O, Guillot I, Paradis V, Joly P, Crickx B, Ranger-Rogez S, Descamps V (2009). "Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure". Arch Dermatol. 145 (1): 67–72. doi:10.1001/archderm.145.1.67. PMID 19153346.
- ↑ Lin YJ, Cheng MC, Lo MH, Chien SJ (2015). "Early Differentiation of Kawasaki Disease Shock Syndrome and Toxic Shock Syndrome in a Pediatric Intensive Care Unit". Pediatr. Infect. Dis. J. 34 (11): 1163–7. doi:10.1097/INF.0000000000000852. PMID 26222065.